ERBB2 and gastric cancer: This study innovatively integrated multiple database analyses, including TCGA, and conducted in vitro experiments to reveal and validate, for the first time, that the downregulation of miR-497-5p in GC inhibits the malignant transformation of GC cells by targeting ERBB2.